Chongqing Pharmaceutical Research Institute Co., Ltd. has received funding from the Bill & Melinda Gates Foundation for the development of a large-scale semi-synthetic Artemisinin processIn July 2018, Chongqing Pharmaceutical Research Institute Co., Ltd (“CPRI”), the Research and Development platform of Fosun Pharma, was awarded with 450,000 USD from the Bill & Melinda Gates Foundation (“Gates Foundation”), a non-profit organization, for the development of a semi-synthetic Artemisinin manufacturing process.Malaria is one of the leading fatal infectious diseases in the world. According to the 2017 World Malaria Report from WHO (World Health Organization), about half of the population in 91 countries around the world are still threatened by malaria, with 216 million malaria cases and 445 thousand malaria deaths reported at the end of 2016. New artemisinin-based combination therapy is used as the first-line treatment for malaria in over 80 countries. Synbiowatch has reported ...
2018
-
08
-
23